Vaccinology is the most cost effective and efficacious of medical interventions for the eradication or management of many infectious diseases. The generation of a cellular immune response is key to survival against a variety of viral and intracellular bacterial pathogens and cancer. Therefore, the development of safe vaccines capable of inducing strong cellular immunity continues to be a pressing challenge for medicine. We have explored the use of an attenuated strain of Listeria monocytogenes as a novel live vaccine vector for this purpose. L. monocytogenes is a gram-positive intracellular bacterial pathogen whose genome has been fully sequenced (22), greatly facilitating detailed studies of its biochemistry, genetics, and physiology and contributing to the existing wealth of knowledge of its adjuvant properties and immunogenicity.
Vaccinology is the most cost effective and efficacious of medical interventions for the eradication or management of many infectious diseases. The generation of a cellular immune response is key to survival against a variety of viral and intracellular bacterial pathogens and cancer. Therefore, the development of safe vaccines capable of inducing strong cellular immunity continues to be a pressing challenge for medicine. We have explored the use of an attenuated strain of Listeria monocytogenes as a novel live vaccine vector for this purpose. L. monocytogenes is a gram-positive intracellular bacterial pathogen whose genome has been fully sequenced (22) , greatly facilitating detailed studies of its biochemistry, genetics, and physiology and contributing to the existing wealth of knowledge of its adjuvant properties and immunogenicity.
Since the early work of Mackaness in the 1960s (30) , L. monocytogenes has been studied extensively as a paradigm for understanding innate and cell-mediated immunity. The organism can enter phagocytic cells through Fc receptors or type I macrophage scavenger receptors (12, 48) and can invade nonphagocytic cells by the interaction of the bacterial surface proteins InlA (16) and InlB (18) with their cognate host cell receptors. Following internalization by phagocytic cells, the majority of engulfed organisms are degraded in the phagosome (11) . However, listeriolysin O (LLO), a pore-forming cytolysin, and PI-PLC, a phosphatidylinositol-specific phospholipase C, mediate permeabilization of the phagosomal membrane, enabling a fraction of the organisms to enter the host cell cytosol (9, 31, 38, 45) . Subsequently, proteins secreted by the organism can be delivered directly into the major histocompatibility complex (MHC) class I pathway of antigen processing and presentation (2, 5) . Mutants of L. monocytogenes unable to enter the cytosol are avirulent. These bacteria fail to stimulate protective immunity in mice, and cells infected by such mutants are not recognized by L. monocytogenes-immune CD8 ϩ T cells (7, 34) . Conversely, mice infected with sublethal doses of wildtype bacteria develop long-lasting immunity, mediated predominantly by CD8 ϩ T cells (13, 29) . This unique property of L. monocytogenes makes it attractive as a potential live vaccine vector, and recombinant strains expressing foreign antigens have successfully protected mice against lymphocytic choriomeningitis (23, 44) , papillomavirus (26) and influenza virus (25) infections, and tumor challenge (24, 36, 37) .
Because of the potential use of this organism as a vaccine vector for protection against infectious diseases and cancer, the safety of L. monocytogenes is a critical issue. While infections by L. monocytogenes are fairly rare and can readily be controlled by a number of antibiotics, the organism can cause meningitis and death, particularly in immunocompromised or pregnant patients. A vaccine strain of L. monocytogenes should therefore be avirulent but immunogenic. We previously sought to generate an attenuated strain that could enter the host cell cytosol but would have limited growth potential there. We reported the first description of a conditional lethal strain of L. monocytogenes with deletions of the dal and dat genes (⌬dal ⌬dat), attenuated by virtue of deletions in the two genes nec-essary for the synthesis of D-alanine, a rare amino acid required for listerial peptidoglycan and lipoteichoic acid formation (15, 27, 40) . This deletion bacterium has potential use as a vaccine vector because D-alanine is found only in trace quantities in vertebrate animals; therefore, the bacterium can survive only as long as D-alanine is supplied exogenously (49) . Brief administration of the amino acid at the time of immunization is adequate to allow sufficient bacterial replication and the induction of an L. monocytogenes-specific immune response in mice. We demonstrated that immunization of mice in this way with a human immunodeficiency virus-gag recombinant of this novel attenuated strain of L. monocytogenes elicited a persistent systemic and mucosal anti-Gag CD8 ϩ cytotoxic T lymphocyte response (39) .
While the use of this strain as a vaccine vector allows complete control over the viability of the organism through the provision or withholding of D-alanine, it is not possible to be certain that the required amount of the amino acid is available at the precise location of the organism in the host in order to achieve optimal immunogenicity. Also, vaccination requires the dual administration of both the organism and the amino acid. We have now attempted to produce a second-generation strain from the D-alanine-deficient ⌬dal ⌬dat strain that would no longer require exogenous administration of the amino acid and yet would still retain a high degree of attenuation. A multicopy plasmid, in which expression of the Bacillus subtilis dal gene was placed under the inducible control of the lac repressor, was introduced into the ⌬dal ⌬dat strain to complement its dal deletion. Racemase, encoded by the dal gene, catalyzes the interconversion of L-alanine and D-alanine. This strategy allows the accumulation of racemase enzyme during preparative growth of the bacterium in the presence of inducer. However, immunization of the host in the absence of inducer is followed by cessation of racemase expression, rapid depletion of the enzyme during successive bacterial division cycles, and death of the organism. In this study, we test and demonstrate the validity of this concept and examine the degree of attenuation and immunogenicity of this new experimental strain.
MATERIALS AND METHODS
Bacterial strains and cell growth conditions. ⌬dal ⌬dat, a hyperattenuated strain of Listeria monocytogenes, was grown in brain heart infusion broth (BHI; Difco, Detroit, MI) at 30°C or 37°C and supplemented with 200 g/ml of Dalanine as described previously (49) . In order to use standardized and known quantities of bacteria, many experiments were performed with thawed cultures prepared from 3-to 4-h growth of overnight cultures diluted to ratios of 1:20. Bacteria were stored at Ϫ80°C in BHI. Escherichia coli strains used for molecular cloning were grown in Luria-Bertani (LB) medium at 37°C with agitation. The following antibiotics were used at the indicated concentrations: ampicillin, 100 g/ml; chloramphenicol (CAM), 10 g/ml; and streptomycin (SM), 50 g/ml. Tissue culture cells were grown in Dulbecco modified Eagle medium (DMEM; Mediatech, Herndon, VA) supplemented with 10% fetal bovine serum and 2 mM L-glutamine (Mediatech) at 37°C in a 5% CO 2 -air atmosphere. Plasmid pKSV7-Bsdal contains the B. subtilis racemase gene dal with 562 upstream base pairs.
Construction of ⌬dal ⌬dat/pLidal. The plasmid pLIV1 (10) contains a SPAC/ lacOid promoter/operator, so genes cloned into its unique downstream XbaI site will be expressed under the transcriptional control of an isopropyl-␤-D-thiogalactopyranoside (IPTG)-inducible promoter. Also present is the lac repressor gene (lacI) constitutively regulated by the L. monocytogenes p60 gene promoter. Primer BsubUp2 (5Ј-GCGTCTAGAAAGCTAGGAAGTGTCGTAATG-3Ј), containing the upstream XbaI site (underlined), and primer BsubHALow (5Ј-C GTCTAGATTATTATGCATAATCTGGAACATCATATGGATAATTGCTT ATATTTACCTGCAATAAAGG-3Ј), containing the downstream XbaI site (underlined) and a hemagglutinin (HA) tag, were used to PCR amplify a promoterless B. subtilis dal gene from pKSV7-Bsdal. The 1,253-bp PCR fragment contained an 18-bp translation initiation signal and dal coding sequence, an HA tag, a downstream translation termination sequence, and XbaI sites at the 5Ј and 3Ј termini. pLIV1/idal (pLidal) was generated by ligating the XbaI-digested B. subtilis racemase gene fragment into the XbaI site of pLIV1. The ⌬dal ⌬dat strain was transformed with pLidal by electroporation. The transformants were selected on BHI-plus-D-alanine-plus-CAM agar plates at 30°C. The plasmidcontaining transformants were further screened on BHI-plus-CAM-plus-IPTG and BHI-plus-CAM agar plates. The resulting IPTG-inducible strain of ⌬dal ⌬dat was named ⌬dal ⌬dat/pLidal.
Construction of ⌬dal ⌬dat/pAidal. A KpnI fragment harboring the idal-expressing cassette from pLidal was cloned into pAM401, generating pAidal, as shown in Fig. 1 . The KpnI fragment was digested with T4 DNA polymerase to form blunt ends and ligated with EcoRV-digested pAM401 vector. The new recombinants were transformed into E. coli XL1-Blue and confirmed by enzyme digestion and then transferred into ⌬dal ⌬dat and characterized on differential plates. This strain was named ⌬dal ⌬dat/pAidal.
The inducible expression of alanine racemase: dependence on IPTG for growth. The idal strains were grown overnight in BHI plus CAM plus IPTG (1 mM). One milliliter of overnight culture was added to 19 ml of BHI-plus-CAM broth, aliquoted into multiple 1-ml cultures, and grown at 30°C (⌬dal ⌬dat/ pLidal) or 37°C (⌬dal ⌬dat/pAidal) in the presence or absence of various concentrations of IPTG. Wild-type L. monocytogenes and the ⌬dal ⌬dat strain in the presence of D-alanine (200 g/ml) were used as controls. At various times, samples were taken for measurement of their optical densities at 600 nm. .
Dependence on IPTG for intracellular growth. The intracellular growth of ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal in J774 cells was studied as previously described (38) , with minor modification. Approximately 1 ϫ 10 6 washed bacteria from a frozen stock culture, previously grown in BHI plus CAM plus IPTG (1 mM), were used to infect 1.5 ϫ 10 6 J774 cells seeded 18 h previously onto 12-mm-diameter glass coverslips in a 60-mm-diameter petri dish. Infection was performed in DMEM without IPTG. At 30 min postinfection, the J774 cells were washed with phosphate-buffered saline (PBS) three times, and DMEM with or without 1 mM IPTG was added. At 1 h postinfection, gentamicin was added to a final concentration of 50 g per ml. The control was ⌬dal ⌬dat in the presence of D-alanine (200 g/ml). Three coverslips were taken from the cultures at 2, 4, 6, 8, and 10 h, separately placed in sterile distilled H 2 O, and vortexed for 15 s to lyse J774 cells. Dilutions were plated on BHI with 200 g/ml of D-alanine to determine the total numbers of viable intracellular bacteria. At 6 h postinfection, the J774 cells were washed with PBS to remove gentamicin from the medium, which was replaced with fresh DMEM medium in the presence or absence of IPTG (1 mM).
Analysis of plaque formation in L2 fibroblasts. Assays of plaque formation in L2 cell monolayers were performed as previously described (47), with some modification. Briefly, L2 cell monolayers were grown to confluence in six-well tissue culture plates. Approximately 2 ϫ 10 5 bacteria from a frozen stock culture were used to infect the monolayers for 1 h in DMEM in the presence of various concentrations of IPTG. Monolayers were washed three times with PBS, and a DMEM-0.7% agarose overlay containing 10 g/ml of gentamicin and various concentrations of IPTG was added. Plates were incubated for 3 days to allow plaque formation. At day 4, the overlay was removed, and the cells were fixed in PBS-10% paraformaldehyde for 60 min, stained with 0.1% crystal violet-20% ethanol for 5 min, washed, and air dried. The diameters of plaques in the monolayers were measured after ϫ10 amplification.
Plasmid stability in vitro and in vivo. (i) In vitro stability was assessed as follows. ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal were cultured for approximately 125 generations in BHI broth in the presence of D-alanine or IPTG and then plated on BHI-plus-D-alanine or BHI-plus-IPTG agar plates. The resulting colonies were further tested on BHI-plus-D-alanine and BHI-plus-IPTG duplicate plates to confirm their phenotypes and subsequently analyzed by PCR to determine the presence of plasmid. (ii) In vivo stability was assessed as follows. Fiveto six-week-old mice were inoculated intravenously (i.v.) with 2 ϫ 10 7 bacteria and sacrificed 24 h later. Splenocytes were lysed in water and plated on BHIplus-D-alanine-plus-SM or BHI-plus-IPTG-plus-CAM-plus-SM agar plates. The ratios of bacterial colonies on these plates were determined, and selected colonies were analyzed by PCR.
Bacterial proliferation in spleen and liver. To examine the virulence of the L. monocytogenes constructs in mice, animals were infected i.v. with 2 ϫ 10 7 ⌬dal ⌬dat cells in the presence of D-alanine, ⌬dal ⌬dat/pLidal cells, or ⌬dal ⌬dat/ pAidal cells or with 2 ϫ 10 3 wild-type L. monocytogenes cells. The numbers of viable bacteria in spleen and liver were determined at days 1, 2, 3, and 7 postinfection. Spleen and liver cells were lysed in H 2 O and H 2 O containing 0.1% NP-40 detergent (Sigma, St. Louis, MO), respectively, and dilutions were plated on BHI plus D-alanine plus SM.
Immunogenicity: LLO-tetramer-specific T cells. Six-to eight-week-old BALB/c (H-2 d haplotype) female mice were infected i.v. with 2 ϫ 10 3 wild-type L. monocytogenes cells, 2 ϫ 10 7 ⌬dal ⌬dat cells in the presence of D-alanine, or 2 ϫ 10 7 ⌬dal ⌬dat/pLidal or ⌬dal ⌬dat/pAidal cells. At day 21 postinfection, some of these animals were boosted at a fivefold-higher dose. Groups of three mice each were sacrificed at day 9 after primary infection or at day 6 after secondary infection. Peritoneal exudate cells, peripheral blood lymphocytes, and splenocytes were collected, the red blood cells were removed with ACK lysis buffer, and the washed lymphocytes were stained with anti-CD8a-fluorescein isothiocyanate, anti-CD11a-phycoerythrin (BD Biosciences, San Diego, CA) and LLO 91-99 -MHC I tetramers labeled with allophycocyanin (NIH). Flow cytometry was performed using a FACSCalibur flow cytometer (Becton Dickinson, Mountain View, CA), and the data were analyzed using FlowJo software (Tree Star, Inc, Ashland, OR).
Immunogenicity: protection. For protection studies, mice were infected with 2 ϫ 10 7 ⌬dal ⌬dat cells in the presence of D-alanine, ⌬dal ⌬dat/pLidal cells, or ⌬dal ⌬dat/pAidal cells and challenged 21 days later with 2 ϫ10 4 wild-type L. monocytogenes cells. The mice were sacrificed at day 3 postchallenge. Spleens were removed for the enumeration of bacteria in these organs.
RESULTS
The inducible expression of alanine racemase in ⌬dal ⌬dat/ pLidal and ⌬dal ⌬dat/pAidal: dependence on IPTG for growth and expression of enzyme. The growth and viability of ⌬dal ⌬dat, the double-deletion strain of L. monocytogenes, is absolutely dependent on an exogenous supply of D-alanine, both in vitro and in vivo (49) . While this provides a high degree of safety and control when these organisms are used as a vaccine, we wanted to explore the possibility of generating a strain based on the attenuation of ⌬dal ⌬dat that would nevertheless obviate the need for exogenous administration of the amino acid. We reasoned that this might be achieved if a gene encoding one of the D-alanine-synthesizing enzymes could be introduced into the bacteria under conditions in which its expression would be tightly regulated, allowing, when desired, a supply of enzyme sufficient to provide for the abundant need for D-alanine for cell wall synthesis, growth, and division or for its complete shutdown at other times.
Gene expression systems for gram-positive bacteria based on ligand-activated repressors, including the mercury resistance operon, activated by free Hg 2ϩ (8) , tetracycline resistance genes, activated by that antibiotic (19) , and the lac repressor/ operator system (53), have been described previously. Recently, plasmid pLIV1, with a lac regulatory cassette that shows stringent regulation and strong dose dependence on the inducer IPTG, has been described for use with L. monocytogenes (10) . Important features of the cassette include multiple tandem copies of a transcriptional terminator that prevents aberrant read-through to the experimental gene, strong constitutive expression of the lac repressor mediated by the L. monocytogenes p60 promoter, and the presence of a modified SPAC/ lacOid promoter/operator sequence that shows affinity for the lac repressor that is six-to eightfold higher than that of the native operator (35) . We have introduced into this expression cassette a promoterless copy of the B. subtilis alanine racemase (dal) gene downstream of the SPAC/lacOid promoter/operator.
The B. subtilis dal gene with an intact 562-bp upstream promoter region, when expressed from the low-copy-number pKSV7 plasmid (pKSV7-Bsdal), fully complements the D-alanine deficiency of ⌬dal ⌬dat during growth in vitro (unpublished data and reference 49). However, the B. subtilis gene, with only 18 upstream base pairs containing a Shine-Dalgarno sequence for ribosome binding, failed to allow any growth of ⌬dal ⌬dat (data not shown). This promoterless dal gene was introduced into the temperature-sensitive pLIV1 construct. The resulting SPAC/lacOid:idal cassette was also transferred to the non-temperature-sensitive plasmid pAM401. We will refer to the double-deletion bacterium containing the pLIV1 plasmid as ⌬dal ⌬dat/pLidal and to that carrying the pAM401 plasmid as ⌬dal ⌬dat/pAidal (Fig. 1) .
Growth of the idal-expressing bacteria, on either plasmid backbone, was found to be absolutely dependent either on D-alanine or, if D-alanine was absent, on IPTG (Fig. 2) . ⌬dal ⌬dat/pAidal and ⌬dal ⌬dat/pLidal began to grow at concentrations of about 0.003 and 0.01 mM IPTG and showed maximal growth rates at 0.1-and 0.5-mM concentrations of IPTG and higher, respectively, which are close to the growth rate of the ⌬dal ⌬dat strain supplemented with D-alanine or of wild-type L. monocytogenes. The more efficient use of inducer by ⌬dal ⌬dat/pAidal may result from its higher copy number. Bacteria from which IPTG had been removed divided once or twice before replication ceased and death of the culture ensued (Fig.  3) . VOL. 73, 2005 A CONDITIONAL LETHAL L. MONOCYTOGENES VACCINE VECTOR 5067
In the presence of IPTG, the idal-expressing bacteria should accumulate alanine racemase enzyme. However, attempts to detect the enzyme by Western blotting, using antibody directed against an HA tag incorporated at the C terminus of the dal gene, yielded no band when lysates of ⌬dal ⌬dat/pLidal were analyzed and only a very faint band from lysates of ⌬dal ⌬dat/ pAidal, whereas analysis of lysates of the ⌬dal ⌬dat strain containing the B. subtilis dal gene with its native promoter on pKSV7 (pKSV7-Bsdal) resulted in an easily detected strong band (Fig. 4, lane 4) . Nevertheless, the SPAC/lacOid promoter was shown to be effective for the inducible expression of racemase in E. coli. Fig. 4 shows a Western blot of E. coli/pLidal containing the HA-tagged dal gene grown in the presence or absence of IPTG. The HA-tagged protein is clearly strongly induced. The ability to detect the racemase protein in E. coli, where it is superfluous, but not in ⌬dal ⌬dat, where it is required, suggests either that significantly more protein is induced in E. coli than in L. monocytogenes, perhaps due to higher plasmid copy number or more favorable synthesis/turnover rates or to the fact that when the enzyme is functional, it may be consumed or altered.
Dependence of ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal on IPTG for intracellular growth in J774 cells. Because the growth of ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal in BHI medium showed strict dependence on IPTG, we next determined whether their growth within a eukaryotic host cell also depended on IPTG induction. Previous data had shown that ⌬dal ⌬dat in the presence of, but not in the absence of, D-alanine was able to replicate in J774 cells, a macrophage-like cell line (49) . Therefore, these cells were infected with ⌬dal ⌬dat/ pLidal and ⌬dal ⌬dat/pAidal for 30 min (in the absence of IPTG) and then subsequently cultured in the presence or the absence of IPTG and gentamicin (50 g/ml). As shown in somewhat during the first 6 h of culture in the presence of gentamicin. However, after removal of the drug at 6 h, these cells grew well if IPTG was present but not if it was absent. The cells attained levels comparable to that of ⌬dal ⌬dat with the continuous presence of D-alanine. In the absence of inducer, only one or two cell divisions occurred. It appears that the idal-expressing bacteria may be sensitive to the high concentration of gentamicin, perhaps because the growth of these cells necessitates the additional burden of synthesizing an amount of racemase enzyme sufficient to satisfy their abundant need for D-alanine. Racemase induction by IPTG is required for growth and cell-to-cell spread of ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal in L2 fibroblasts. To evaluate the racemase requirement for cellto-cell spread, we used the idal-expressing strains in a plaque formation assay in murine L2 fibroblasts, a nonprofessional phagocytic cell line. As shown in Fig. 6 , no plaques were formed in L2 cell monolayers infected with either ⌬dal ⌬dat/ pLidal or ⌬dal ⌬dat/pAidal in the absence of IPTG. Only when IPTG was present throughout the entire infection period were large plaques visible in the monolayers. The average diameter of ⌬dal ⌬dat/pLidal plaques in the presence of 1 mM of IPTG was less than that of plaques following infection with ⌬dal ⌬dat/pAidal or infection in the presence of D-alanine. Table 1 shows that plaque diameter was dependent on the concentration of IPTG and that ⌬dal ⌬dat/pAidal made plaques that were larger and detectable at lower concentrations than those seen with ⌬dal ⌬dat/pLidal. At very high IPTG concentrations, plaque diameter decreased, likely due to the toxicity of IPTG (10, 52) .
Plasmid stability in vitro and in vivo. The survival of the ⌬dal ⌬dat strain in the absence of D-alanine depends on retention of the idal plasmids. We therefore wondered how stable the idal plasmids were in the absence of selective antibiotics. The issue of stability is especially important in vivo, since the bacteria have been designed for use as vaccines. As shown in Table 2 , both ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal lost all plasmid after about 125 generations of in vitro culture in BHI medium in the presence of D-alanine, a condition that exerts no selective pressure for plasmid retention. However, in the presence of IPTG but absence of D-alanine, all viable bacteria contained plasmid after 125 generations. Thus, bacteria that must rely on endogenous racemase for D-alanine production retain their plasmids. If any bacteria had lost plasmid, the resulting racemase-deficient bacteria would have quickly expired and been replaced by plasmid-containing organisms.
We examined the in vivo retention of plasmid as well for mice at 24 h postinfection, when only a fraction of the bacteria were found to still survive in the spleen (see Fig. 7 ). As shown in Table 2 , only 25% of the surviving organisms retained the pLidal plasmid, while 66% retained the pAidal plasmid. The surviving non-plasmid-containing bacteria may temporarily be sustained by accumulated racemase. These in vivo data indicate that ⌬dal ⌬dat/pAidal is more stable in vivo.
Accelerated clearance of ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/ pAidal in mice. To assess the safety of the organisms, the number of bacteria found in tissues of infected host animals was examined at various times after infection. Groups of mice were infected intravenously with 2 ϫ 10 7 ⌬dal ⌬dat/pLidal cells, ⌬dal ⌬dat/pAidal cells, or ⌬dal ⌬dat cells plus D-alanine or with 2 ϫ 10 3 wild-type L. monocytogenes cells, and the total number of viable bacteria in spleens and livers was assessed on BHI-plus-D-alanine-plus-SM plates at various times up to 7 days postinfection. As indicated in Fig. 7 , wild-type L. monocytogenes multiplied in these organs and reached a maximum at days 2 to 3 and were then eliminated by the host immune response. In contrast, ⌬dal ⌬dat plus D-alanine, ⌬dal ⌬dat/ pLidal, and ⌬dal ⌬dat/pAidal failed to replicate significantly and were cleared from spleen and liver within 2 to 3 days. This rapid clearance agrees with preliminary tests that indicate that the 50% lethal doses of both of these organisms are approximately 10 8 or higher (data not shown). Immunogenicity: LLO-specific CD8 T cells. LLO, the major virulence factor for L. monocytogenes pathogenesis, is responsible for lysing the phagocytic vacuole to allow bacterial access to the cytosol (17, 28) . This protein also contains the dominant CD8 ϩ T cell epitope of L. monocytogenes (51) . To assess the level of induction of activated LLO-specific CD11a ϩ CD8 ϩ effector T cells following immunization of mice with ⌬dal ⌬dat/ pLidal and ⌬dal ⌬dat/pAidal, lymphocytes from spleen, peritoneal exudate, and peripheral blood were analyzed during FIG. 6 . Induction of racemase in ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/ pAidal is required for cell-to-cell spread in mouse L2 fibroblasts. Wildtype L. monocytogenes (Lmϩ), ⌬dal ⌬dat plus 200 g/ml D-alanine (Lmdd ϩ D), ⌬dal ⌬dat/pLidal (Lidal), and ⌬dal ⌬dat/pAidal (Aidal), the latter two in the presence or absence of 1 mM IPTG (I), were added to monolayers of L2 fibroblasts and incubated for 1 h (the result for ⌬dal ⌬dat/pAidal in the absence of IPTG is not shown). Following washing with PBS, the infected cell monolayers were overlaid with agarose containing BHI medium plus gentamicin Ϯ IPTG. Plaque formation following intracellular growth and spread of bacteria was visualized at 96 h postinfection. a ⌬dal ⌬dat/pLidal or ⌬dal ⌬dat/pAidal, grown in BHI broth containing 1 mM IPTG, were washed and used to infect monolayers of mouse L2 fibroblasts for 1 h at the indicated concentrations of IPTG. After washing the monolayers, an agarose overlay containing medium, gentamicin, and IPTG was added. Plaque formation was visualized after a 96-h incubation at 37°C. Plaque diameters are given as percentages of plaques produced by ⌬dal ⌬dat plus D-alanine (200 g/ml).
VOL. 73, 2005
A CONDITIONAL LETHAL L. MONOCYTOGENES VACCINE VECTOR 5069 primary and secondary responses by flow cytometry. As shown in Fig. 8 , wild-type L. monocytogenes, the positive control, elicited the highest percentage of LLO-specific CD11a ϩ CD8 ϩ T cells in spleen during the primary response relative to the other strains tested. However, during a secondary response, the attenuated strains, i.e., ⌬dal ⌬dat plus D-alanine, ⌬dal ⌬dat/pLidal, and ⌬dal ⌬dat/pAidal, showed responses significantly higher than that of wild-type L. monocytogenes in all the tissues tested. Immunogenicity: protection against challenge by wild-type L. monocytogenes. To determine whether infection of mice with sublethal doses of ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal could induce long-lasting protective immunity, we injected mice intravenously with 2 ϫ 10 7 ⌬dal ⌬dat/pLidal cells, ⌬dal ⌬dat/pAidal cells, or ⌬dal ⌬dat cells plus D-alanine or with 2 ϫ 10 3 wild-type L. monocytogenes cells and subsequently challenged the mice with 2 ϫ 10 4 wild-type L. monocytogenes cells 3 weeks later. As shown in Fig. 9 , the levels of viable bacteria remaining in the spleens of mice immunized by ⌬dal ⌬dat/ pLidal and ⌬dal ⌬dat/pAidal were similar to that following ⌬dal ⌬dat-plus-D-alanine immunization, with more than a 2-log 10 -unit reduction compared to the naïve group. However, immunization with 2 ϫ 10 3 wild-type L. monocytogenes cells provided the greatest protection.
DISCUSSION
L. monocytogenes has long served as a model for the study of innate and cellular immunity and recently has been viewed as a potential live vaccine vehicle for infectious diseases and cancer (4, 7, 14, 21, 30, 41, 43, 50) . However, the organism can cause listeriosis, a serious food-borne illness for certain populations at risk, such as neonates and infants, pregnant women, elderly persons, and immunocompromised individuals (20, 32, 42) . The most common clinical findings include meningitis, septicemia, encephalitis, and intrauterine/cervical infections. Even though the incidence of natural infection is low, it is of significant concern if L. monocytogenes strains are to be used as human vaccine vectors. The organism must not only be attenuated sufficiently so as to pose little risk for highly susceptible hosts but must also retain the ability to elicit the desired immune response.
A candidate safe vaccine vector, an L. monocytogenes strain with deletions of the dal and dat genes (⌬dal ⌬dat) is a highly attenuated strain, with its growth fully controlled by the exogenous administration of D-alanine. It was shown to effectively induce protective immunity against challenge either by the wild-type organism itself or by other organisms expressing a common antigen when infection was initiated with a small dose of D-alanine (39, 49) .
In the present report, we have devised conditional lethal forms of the ⌬dal ⌬dat vector, called ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal, designed to overcome the shortcoming of the need for external administration of D-alanine. In these new constructs, we chose to use the homologous B. subtilis racemase gene to complement the racemase deletion in the ⌬dal ⌬dat strain. The deduced protein sequence of L. monocytogenes alanine racemase shares only 50% identity with that of the B. subtilis racemase, yet the protein of B. subtilis, regulated by its natural 562-bp upstream promoter region, fully complemented the D-alanine deficiency of ⌬dal ⌬dat during growth in vitro when expressed from a low-copy-number plasmid (unpublished data and reference 49). However, the restricted homology of the two genes substantially reduced the possibility of recombination and the potential regeneration of dal ϩ on the L. monocytogenes chromosome. In the new constructs, the B. subtilis racemase (dal) gene, with only a short Shine-Dalgarnosequence-containing 18-bp upstream region, was placed downstream of the SPAC/lacOid IPTG-inducible promoter to assure tight control of the gene by IPTG. This construct completely failed to grow without D-alanine, while the presence of IPTG allowed uninhibited growth.
Use of the pLIV1 plasmid (10), harboring regions of homology with the L. monocytogenes chromosome, allows integration of the IPTG-regulated cassette into the chromosome. We chose not to use this approach to achieve D-alanine independence of the ⌬dal ⌬dat strain. First, the synthesis of cell wall components in a growing population of L. monocytogenes cells requires abundant D-alanine, both for peptidoglycan formation (27) and for lipoteichoic acid synthesis (1, 40) . We surmised that a single copy of the B. subtilis dal gene controlled by the fairly weak SPAC/lacOid promoter would not satisfy this need. Even the requirement for the actA gene product by Listeria is not satisfied with a single copy of the pLIV1 cassette (unpublished observation). Conversely, multiple copies of the plasmid should assure an abundant supply of enzyme to support bacterial growth. This in fact did allow full growth of ⌬dal ⌬dat, which has a deletion of racemase. Nevertheless it still proved difficult to detect racemase by Western blotting. Multiple copies of the lac repressor gene also assured that mutations on any individual plasmid leading to inducer-independent gene ex- pression would have negligible effects on the control of the system. The two new constructs that we generated, ⌬dal ⌬dat/pLidal and ⌬dal ⌬dat/pAidal, both contain a promoterless B. subtilis dal gene under the control of the SPAC/lacOid promoter, complementing the dal gene defect of ⌬dal ⌬dat when expression was induced by IPTG. Both constructs had the desired property of complete dependence on the inducer for growth with no requirement for exogenous D-alanine. Thus, growth in laboratory medium and intercellular spread in culture were stringently dependent upon IPTG. These organisms, unlike ⌬dal ⌬dat, carry their own transient in situ supply of racemase. Therefore, following mouse infection, regardless of the route of infection or the site of in vivo replication, they may satisfy their need for D-alanine more efficiently than ⌬dal ⌬dat. In the absence of IPTG, the strains were very rapidly depleted from the spleens and livers of infected animals, days before a sublethal dose of wild-type L. monocytogenes reached maximal growth and almost a week before wild-type L. monocytogenes was eliminated. Despite this short survival time in mice, the strains were able to induce effective immune responses. They elicited strong LLO-tetramer-specific CD8 ϩ T cell responses and provided protection against challenge by wild-type L. monocytogenes at levels similar to that provided by ⌬dal ⌬dat-plus-D-alanine administration. The CD8 ϩ T cell response was weaker than that elicited by wild-type L. monocytogenes after primary immunization but significantly stronger than that of wild-type L. monocytogenes after a boost, perhaps as a result of the greater amount of antigen that could be introduced with these attenuated organisms. It is therefore possible that after a boost, these new strains might provide stronger protection against challenge than could be provided by wild-type L. monocytogenes. Thus, despite the rapid death of the organisms in infected animals, they nevertheless elicited strong immune responses that were able to protect against subsequent challenge by the wild-type organism.
Since we did not utilize the integrative property of pLidal, the pAidal plasmid showed multiple advantages over pLidal. First, the electroporation of pAidal into competent L. monocytogenes was considerably more efficient than that of pLidal. In addition, the fact that it is not temperature sensitive and is a higher-copy-number plasmid may account for the better retention of pAidal by ⌬dal ⌬dat both in culture and in vivo. These characteristics may have led to the somewhat better induction of immune CD8 ϩ T cells by pAidal, as the duration of in vivo bacterial growth during the first day after infection may determine the magnitude of the LLO-specific T-cell response (33) . Furthermore, it has been observed that during growth at low temperatures the pLIV1 plasmid can integrate into the chromosome at its homology regions, thus allowing secondary integration events to occur more readily (unpublished data). This suggests that some uncertainty is associated with the use of pLIV1-derived vectors as nonintegrative plasmids.
In summary, we have characterized a new vaccine system for L. monocytogenes based on ⌬dal ⌬dat, a D-alanine-requiring auxotroph. This new bacterium satisfies its need for D-alanine through conditional expression of a racemase gene from an IPTG-inducible promoter. The bacterium shows complete dependence on IPTG, is avirulent in mice, and results in an effective immune response that leads to protection against subsequent challenge. ⌬dal ⌬dat/pAidal may be a good candidate for a live bacterial vaccine vector. In an attempt to satisfy the important medical need for vectors able to elicit cellular immunity, several potential new vaccine strains of L. monocytogenes have recently been reported (3, 6, 46) . Further study of our idal system and comparative examination of all of these new strains should focus on their relative safety and explore the quality of the immunogenicity of passenger foreign genes expressed by the vectors.
